Genetic Screening

Genetic Screening

Genetic screening as part of your fertility treatment, which may include IVF, can improve the chance of success and potentially reduce your time in care. When validated forms of preimplantation screening (PGS), also known as comprehensive chromosome screening (CCS), or preimplantation genetic diagnosis (PGD) are used, they can provide patients and providers with powerful information to support a healthy pregnancy and delivery.

The benefits of CCS are many:

  • Allows the embryologist to accurately select the highest quality embryo(s) for transfer
  • Selecting high-quality embryos improves implantation rates and reduces miscarriage rates
  • Greatly increases the effectiveness of single embryo transfer (SET)
  • Reduces the risks associated with becoming pregnant with multiples.  These risks include increased risk of premature birth and low birth weight babies, increased risk of C-section and time spent in neonatal intensive care units, as well as health risks to the mother.

RMANJ knows that preimplantation genetic diagnosis/screening can provide hopeful parents with unparalleled peace of mind. It can be of remarkable benefit in IVF as it further ensures that only the healthiest embryos are ultimately implanted. Patients should know that RMANJ uses the most rigorously validated and widely used CCS platform. CCS testing is provided to RMANJ for the Foundation for Embryonic Competence.

Ask your RMANJ care team if comprehensive chromosome screening (CCS) and preimplantation genetic diagnosis (PGD) is right for you.

For more information on genetic screening, please contact us today.